Ironwood Pharmaceuticals, Inc. - Class A IRWD
$4.25
+2.91%
at last close
Analyst Consensus
- Consensus Rating
- Moderate Buy (1 Buy · 1 Hold · 0 Sell)
- Average Price Target
- $7.50
- Implied Upside
- +76.5%
- Price Target Range
- $5.00 – $10.00
- Analysts (12 mo)
- 2
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-02-26 | CitizensJason N. Butler |
Maintains | Market outperform | $8 → $10 |
| 2026-01-05 | Wells FargoMohit Bansal |
Maintains | Equal-weight | $3 → $5 |
| 2026-01-05 | CitizensJason Butler |
Upgrades | Market perform → Market outperform | $8 |
| 2025-11-11 | Wells FargoMohit Bansal |
Maintains | Equal-weight | $1 → $3 |
| 2025-04-15 | Wells FargoMohit Bansal |
Downgrades | Overweight → Equal-weight | $7 → $1 |
| 2025-04-15 | JefferiesAmy Li |
Downgrades | Buy → Hold | $8 → $1 |
| 2025-04-14 | Leerink PartnersFaisal Khurshid |
Maintains | Market perform | $3 → $1 |
| 2025-01-30 | JMP SecuritiesRoy Buchanan |
Maintains | Market outperform | $23 → $14 |
| 2025-01-22 | Craig-HallumChase Knickerbocker |
Maintains | Buy | $10 → $8 |
| 2024-09-09 | Leerink PartnersFaisal Khurshid |
Initiates coverage on | Market perform | $5 |
| 2024-08-09 | Wells FargoMohit Bansal |
Maintains | Overweight | $14 → $12 |
| 2024-08-09 | Craig-HallumChase Knickerbocker |
Maintains | Buy | $14 → $10 |
| 2024-05-10 | Craig-HallumChase Knickerbocker |
Maintains | Buy | $18 → $14 |
| 2024-03-01 | Wells FargoMohit Bansal |
Maintains | Overweight | $20 → $14 |
| 2024-02-16 | Piper SandlerDavid Amsellem |
Maintains | Overweight | $20 → $21 |
| 2024-01-17 | Craig-HallumChase Knickerbocker |
Initiates coverage on | Buy | $21 |
| 2023-12-14 | Wells FargoMohit Bansal |
Initiates coverage on | Overweight | $20 |
| 2023-09-28 | JMP SecuritiesJason Butler |
Initiates coverage on | Market outperform | $22 |
| 2023-05-23 | Piper SandlerDavid Amsellem |
Maintains | Overweight | $16 → $19 |
| 2022-08-16 | Wells FargoJacob Hughes |
Maintains | Equal-weight | $12 → $13 |
| 2022-04-22 | Piper SandlerDavid Amsellem |
Initiates coverage on | Overweight | $16 |
| 2021-10-12 | Morgan StanleyDavid Lebowitz |
Maintains | Equal-weight | $13 → $14 |
| 2021-07-16 | Morgan StanleyDavid Lebowitz |
Maintains | Equal-weight | $11 → $12 |
| 2021-02-22 | Morgan StanleyDavid Lebovitz |
Maintains | Equal-weight | $12 → $11 |
| 2021-02-19 | Morgan StanleyDavid Lebovitz |
Maintains | Equal-weight | $12 → $11 |
| 2020-11-06 | Credit Suisse |
Maintains | Neutral | $11 → $12 |
| 2020-11-06 | Morgan StanleyDavid Lebovitz |
Maintains | Equal-weight | $11 → $12 |
| 2020-09-30 | Wells FargoJacob Hughes |
Downgrades | Overweight → Equal-weight | $9 |
| 2020-08-07 | Morgan StanleyDavid Lebovitz |
Maintains | Equal-weight | $10 → $11 |
| 2020-07-15 | Morgan StanleyDavid Lebovitz |
Maintains | Equal-weight | $11 → $10 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $4.25
- Market Cap
- $682.44 million
- 52-Week Range
- $0.71 – $5.78
- Average Volume
- 1.97 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.